Skip to content

A Study to Explore the Association Between Blood Pressure, HIV and Antiretroviral Therapy

A Study to Explore the Association Between Blood Pressure, HIV and Antiretroviral Therapy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00131807
Enrollment
3000
Registered
2005-08-19
Start date
2005-09-30
Completion date
2006-09-30
Last updated
2015-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Keywords

Blood Pressure, HIV, Antiretroviral therapy

Brief summary

The purpose of this study is to explore the association between blood pressure, HIV and/or its treatment in a cross sectional observational study.

Detailed description

Deaths from AIDS have declined dramatically since the introduction of highly active antiretroviral therapy in HIV infected patients. However the incidence of heart disease has increased four-fold and is now one of the major causes of death in HIV infected patients. While HIV drugs are known to adversely affect serum lipids, the evidence concerning the association between raised blood pressure (a major risk for cardiovascular disease) HIV and/or its treatment is limited and conflicting. The researchers believe it of interest to study heart disease risk factors in patients with HIV infection to avoid one premature cause of death (AIDS) being replaced with another potentially preventable cause of death and disability (heart disease). In this cross sectional observational study the researchers will systematically measure blood pressure and other cardiovascular risk factors in HIV positive patients on and off antiretroviral therapy. These individuals will be matched for age, sex and ethnic group with HIV negative individuals.

Interventions

PROCEDUREBlood Pressure Measurement
PROCEDUREQuestionnaire

Sponsors

The Hypertension Trust
CollaboratorUNKNOWN
Imperial College London
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Attending St. Mary's sexual health outpatient department * Patients willing to give written informed consent * Ability to communicate in English

Exclusion criteria

* Failure to give written informed consent in English

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026